A universal strategy for stable intracellular antibodies

Journal of Immunological Methods

Volumn 303, Issue 1-2, 2005, Pages 19-39

  Shaki Loewenstein, Shelly ^a   Zfania, Rahely ^a   Hyland, Stephen ^b   Wels, Winfried S ^b   Benhar, Itai ^a  

^a TEL AVIV UNIVERSITY   (Israel)

^b INSTITUTE FOR TUMOR BIOLOGY AND EXPERIMENTAL THERAPY   (Germany)

Author keywords

Cytoplasmic intrabodies; Fusion protein; Maltose binding protein; Molecular chaperone; scFv fragments

Indexed keywords

BETA GALACTOSIDASE; CHAPERONE; EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY; HYBRID PROTEIN; MALTOSE BINDING PROTEIN; SINGLE CHAIN FRAGMENT VARIABLE ANTIBODY;

ANIMAL CELL; ANIMAL TISSUE; ANTIBODY DETECTION; ARTICLE; BACTERIOPHAGE; CONTROLLED STUDY; CYTOPLASM; EMBRYO; HUMAN; HUMAN CELL; MAMMAL CELL; MOUSE; NONHUMAN; PREDICTION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STABILITY; STATISTICAL SIGNIFICANCE; WILD TYPE;

ANIMALS; ANTIBODIES; BETA-GALACTOSIDASE; CELL LINE; CELL LINE, TUMOR; CERCOPITHECUS AETHIOPS; COS CELLS; HUMANS; IMMUNOBLOTTING; IMMUNOGLOBULIN FRAGMENTS; IMMUNOGLOBULIN VARIABLE REGION; INTRACELLULAR FLUID; LAC OPERON; PROTEIN FOLDING; RECEPTOR, EPIDERMAL GROWTH FACTOR;

ESCHERICHIA COLI; MAMMALIA;

EID: 23844516816     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2005.05.004     Document Type: Article

References (81)

1. M. Azemar, M. Schmidt, F. Arlt, P. Kennel, B. Brandt, A. Papadimitriou, B. Groner, and W. Wels Recombinant antibody toxins specific for ErbB2 and EGF receptor inhibit the in vitro growth of human head and neck cancer cells and cause rapid tumor regression in vivo Int. J. Cancer 86 2000 269
2. H. Bach, Y. Mazor, S. Shaky, A. Shoham-Lev, Y. Berdichevsky, D.L. Gutnick, and I. Benhar Escherichia coli maltose-binding protein as a molecular chaperone for recombinant intracellular cytoplasmic single-chain antibodies J. Mol. Biol. 312 2001 79
3. R.R. Beerli, W. Wels, and N.E. Hynes Autocrine inhibition of the epidermal growth factor receptor by intracellular expression of a single-chain antibody Biochem. Biophys. Res. Commun. 204 1994 666
4. I. Benhar Biotechnological applications of phage and cell display Biotechnol. Adv. 19 2001 1
5. I. Benhar, and Y. Reiter Phage display of single-chain antibodies J. Colligan Current Protocols in Immunology vol. 3 2001 John Wiley & Sons, Inc. USA 10.19B.1
6. I. Benhar, C. Miller, and H. Engelberg-Kulka Frameshifting in the expression of the Escherichia coli trpR gene Mol. Microbiol. 6 1992 2777
7. I. Benhar, R. Azriel, L. Nahary, S. Shaky, Y. Berdichevsky, A. Tamarkin, and W. Wels Highly efficient selection of phage antibodies mediated by display of antigen as Lpp-OmpA' fusions on live bacteria J. Mol. Biol. 301 2000 893
8. S. Biocca, P. Pierandrei-Amaldi, N. Campioni, and A. Cattaneo Intracellular immunization with cytosolic recombinant antibodies Biotechnology 12 1994 396
9. S. Biocca, F. Ruberti, M. Tafani, P. Pierandrei-Amaldi, and A. Cattaneo Redox state of single chain Fv fragments targeted to the endoplasmic reticulum, cytosol and mitochondria Biotechnology 13 1995 1110
10. R.E. Bird, K.D. Hardman, J.W. Jacobson, S. Johnson, B.M. Kaufman, S.M. Lee, T. Lee, S.H. Pope, G.S. Riordan, and M. Whitlow Single-chain antigen-binding proteins Science 242 1988 423
11. T.R. Butt, S. Jonnalagadda, B.P. Monia, E.J. Sternberg, J.A. Marsh, J.M. Stadel, D.J. Ecker, and S.T. Crooke Ubiquitin fusion augments the yield of cloned gene products in Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 86 1989 2540
12. A. Cattaneo, and S. Biocca The selection of intracellular antibodies Trends Biotechnol. 17 1999 115
13. F. Celada, R. Strom, and K. Bodlund Antibody mediated activation of a defective β-galactosidase (AMEF). Characterization of binding and activation processes J.H. Miller W.S. Reznikoff The Operon 1978 Cold Spring Harbor Laboratory Press Cold Spring Harbor, NY 291
14. R.J. Center, B. Kobe, K.A. Wilson, T. Teh, G.J. Howlett, B.E. Kemp, and P. Poumbourios Crystallization of a trimeric human T cell leukemia virus type 1 gp21 ectodomain fragment as a chimera with maltose-binding protein Protein Sci. 7 1998 1612
15. P. Chames, J. Fieschi, and D. Baty Production of a soluble and active MBP-scFv fusion: favorable effect of the leaky tolR strain FEBS Lett. 405 1997 224
16. F. Ciardiello, R. Caputo, T. Troiani, G. Borriello, E.R. Kandimalla, S. Agrawal, J. Mendelsohn, A.R. Bianco, and G. Tortora Antisense oligonucleotides targeting the epidermal growth factor receptor inhibit proliferation, induce apoptosis, and cooperate with cytotoxic drugs in human cancer cell lines Int. J. Cancer 93 2001 172
17. P.A. Cohen, J.C. Mani, and D.P. Lane Characterization of a new intrabody directed against the N-terminal region of human p53 Oncogene 17 1998 2445
18. P.S. Daugherty, M.J. Olsen, B.L. Iverson, and G. Georgiou Development of an optimized expression system for the screening of antibody libraries displayed on the Escherichia coli surface Protein Eng. 12 1999 613
19. G. De Jaeger, E. Buys, D. Eeckhout, C. De Wilde, A. Jacobs, J. Kapila, G. Angenon, M. Van Montagu, T. Gerats, and A. Depicker High level accumulation of single-chain variable fragments in the cytosol of transgenic Petunia hybrida Eur. J. Biochem. 259 1999 426
20. A. Desiderio, R. Franconi, M. Lopez, M.E. Villani, F. Viti, R. Chiaraluce, V. Consalvi, D. Neri, and E. Benvenuto A semi-synthetic repertoire of intrinsically stable antibody fragments derived from a single-framework scaffold J. Mol. Biol. 310 2001 603
21. C. di Guan, P. Li, P.D. Riggs, and H. Inouye Vectors that facilitate the expression and purification of foreign peptides in Escherichia coli by fusion to maltose-binding protein Gene 67 1988 21
22. L. Duan, O. Bagasra, M.A. Laughlin, J.W. Oakes, and R.J. Pomerantz Potent inhibition of human immunodeficiency virus type 1 replication by an intracellular anti-Rev single-chain antibody Proc. Natl. Acad. Sci. U. S. A. 1994 5075
23. A. Einhauer, M. Schuster, E. Wasserbauer, and A. Jungbauer Expression and purification of homogenous proteins in Saccharomyces cerevisiae based on ubiquitin-FLAG fusion Protein Expr. Purif. 24 2002 497
24. M.J. Feldhaus, R.W. Siegel, L.K. Opresko, J.R. Coleman, J.M. Feldhaus, Y.A. Yeung, J.R. Cochran, P. Heinzelman, D. Colby, J. Swers, C. Graff, H.S. Wiley, and K.D. Wittrup Flow-cytometric isolation of human antibodies from a nonimmune Saccharomyces cerevisiae surface display library Nat. Biotechnol. 21 2003 163
25. J.D. Fox, R.B. Kapust, and D.S. Waugh Single amino acid substitutions on the surface of Escherichia coli maltose-binding protein can have a profound impact on the solubility of fusion proteins Protein Sci. 10 2001 622
26. C. Frisch, H. Kolmar, A. Schmidt, G. Kleemann, A. Reinhardt, E. Pohl, I. Uson, T.R. Schneider, and H.J. Fritz Contribution of the intramolecular disulfide bridge to the folding stability of REIv, the variable domain of a human immunoglobulin kappa light chain Fold. Des. 1 1996 431
27. N. Gargano, and A. Cattaneo Inhibition of murine leukaemia virus retrotranscription by the intracellular expression of a phage-derived anti-reverse transcriptase antibody fragment J. Gen. Virol. 78 1997 2591
28. F. Gennari, S. Mehta, Y. Wang, A. St Clair Tallarico, G. Palu, and W.A. Marasco Direct phage to intrabody screening (DPIS): demonstration by isolation of cytosolic intrabodies against the TES1 site of Epstein Barr virus latent membrane protein 1 (LMP1) that block NF-kappaB transactivation J. Mol. Biol. 335 2004 193
29. G.N. Gill, T. Kawamoto, C. Cochet, A. Le, J.D. Sato, H. Masui, C. McLeod, and J. Mendelsohn Monoclonal anti-epidermal growth factor receptor antibodies which are inhibitors of epidermal growth factor binding and antagonists of epidermal growth factor binding and antagonists of epidermal growth factor-stimulated tyrosine protein kinase activity J. Biol. Chem. 259 1984 7755
30. R. Glockshuber, M. Malia, I. Pfitzinger, and A. Plückthun A comparison of strategies to stabilize immunoglobulin Fv-fragments Biochemistry 29 1990 1362
31. J.E. Grim, G.P. Siegal, R.D. Alvarez, and D.T. Curiel Intracellular expression of the anti-erbB-2 sFv N29 fails to accomplish efficient target modulation Biochem. Biophys. Res. Commun. 250 1998 699
32. J. Hanes, L. Jermutus, S. Weber-Bornhauser, H.R. Bosshard, and A. Plückthun Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries Proc. Natl. Acad. Sci. U. S. A. 95 1998 14130
33. A. Hayhurst Improved expression characteristics of single-chain Fv fragments when fused downstream of the Escherichia coli maltose-binding protein or upstream of a single immunoglobulin-constant domain Protein Expr. Purif. 18 2000 1
34. A. Hershko, and A. Ciechanover The ubiquitin system Annu. Rev. Biochem. 67 1998 425
35. J.S. Huston, D. Levinson, M. Mudgett-Hunter, M.S. Tai, J. Novotny, M.N. Margolies, R.J. Ridge, R.E. Bruccoleri, E. Haber, and R. Crea Protein engineering of antibody binding sites: recovery of specific activity in an anti-digoxin single-chain Fv analogue produced in Escherichia coli Proc. Natl. Acad. Sci. U. S. A. 85 1988 5879
36. S. Hyland, R.R. Beerli, C.F. Barbas, N.E. Hynes, and W. Wels Generation and functional characterization of intracellular antibodies interacting with the kinase domain of human EGF receptor Oncogene 22 2003 1557
37. C.B. Jannot, R.R. Beerli, S. Mason, W.J. Gullick, and N.E. Hynes Intracellular expression of a single-chain antibody directed to the EGFR leads to growth inhibition of tumor cells Oncogene 13 1996 275
38. R.B. Kapust, and D.S. Waugh Escherichia coli maltose-binding protein is uncommonly effective at promoting the solubility of polypeptides to which it is fused Protein Sci. 8 1999 1668
39. R.B. Kapust, and D.S. Waugh Controlled intracellular processing of fusion proteins by TEV protease Protein Expr. Purif. 19 2000 312
40. A. Ke, and C. Wolberger Insights into binding cooperativity of MATa1/MATalpha2 from the crystal structure of a MATa1 homeodomain-maltose binding protein chimera Protein Sci. 12 2003 306
41. B. Kobe, R.J. Center, B.E. Kemp, and P. Poumbourios Crystal structure of human T cell leukemia virus type 1 gp21 ectodomain crystallized as a maltose-binding protein chimera reveals structural evolution of retroviral transmembrane proteins Proc. Natl. Acad. Sci. U. S. A. 96 1999 4319
42. E.R. LaVallie, and J.M. McCoy Gene fusion expression systems in Escherichia coli Curr. Opin. Biotechnol. 6 1995 501
43. E.R. LaVallie, E.A. DiBlasio, S. Kovacic, K.L. Grant, P.F. Schendel, and J.M. McCoy A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm Biotechnology 11 1993 187
44. C. Leclerc, R. Lo-Man, A. Charbit, P. Martineau, J.M. Clement, and M. Hofnung Immunogenicity of viral B- and T-cell epitopes expressed in recombinant bacterial proteins Int. Rev. Immunol. 11 1994 123
45. M. Li, C.L. Brooks, F. Wu-Baer, D. Chen, R. Baer, and W. Gu Mono-versus polyubiquitination: differential control of p53 fate by Mdm2 Science 302 2003 1972
46. Y. Liu, A. Manna, R. Li, W.E. Martin, R.C. Murphy, A.L. Cheung, and G. Zhang Crystal structure of the SarR protein from Staphylococcus aureus Proc. Natl. Acad. Sci. U. S. A. 98 2001 6877
47. D.P. Malinowski, M. Gourley, S. Edelstein, and R.E. Pearson Expression of a chlamydia anticarbohydrate single-chain antibody as a maltose binding fusion protein Cell Biophys. 21 1992 1
48. W.A. Marasco Intrabodies: turning the humoral immune system outside in for intracellular immunization Gene Ther. 4 1997 11
49. W.A. Marasco Intrabodies as antiviral agents Curr. Top. Microbiol. Immunol. 260 2001 247
50. P. Martineau, and J.M. Betton In vitro folding and thermodynamic stability of an antibody fragment selected in vivo for high expression levels in Escherichia coli cytoplasm J. Mol. Biol. 292 1999 921
51. P. Martineau, C. Leclerc, and M. Hofnung Modulating the immunological properties of a linear B-cell epitope by insertion into permissive sites of the MalE protein Mol. Immunol. 33 1996 1345
52. P. Martineau, P. Jones, and G. Winter Expression of an antibody fragment at high levels in the bacterial cytoplasm J. Mol. Biol. 280 1998 117
53. J. Mendelsohn, and J. Baselga Status of epidermal growth factor receptor antagonists in the biology and treatment of cancer J. Clin. Oncol. 21 2003 2787
54. A.M. Mhashilkar, J. Bagley, S.Y. Chen, A.M. Szilvay, D.G. Helland, and W.A. Marasco Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies EMBO J. 14 1995 1542
55. P.A. Nygren, S. Stahl, and M. Uhlen Engineering proteins to facilitate bioprocessing Trends Biotechnol. 12 1994 184
56. L. Persic, M. Righi, A. Roberts, H.R. Hoogenboom, A. Cattaneo, and A. Bradbury Targeting vectors for intracellular immunisation Gene 187 1997 1
57. A.L. Pilon, P. Yost, T.E. Chase, G.L. Lohnas, and W.E. Bentley High-level expression and efficient recovery of ubiquitin fusion proteins from Escherichia coli Biotechnol. Prog. 12 1996 331
58. K. Proba, A. Honegger, and A. Plückthun A natural antibody missing a cysteine in VH: consequences for thermodynamic stability and folding J. Mol. Biol. 265 1997 161
59. Y. Reiter, U. Brinkmann, S.H. Jung, I. Pastan, and B. Lee Disulfide stabilization of antibody Fv: computer predictions and experimental evaluation Protein Eng. 8 1995 1323
60. J. Sambrook, D.W. Russell, and T. Maniatis Molecular Cloning: A Laboratory Manual 1989 Cold Spring Harbor Laboratory Cold Spring Harbor, NY
61. M. Schmidt, N.E. Hynes, B. Groner, and W. Wels A bivalent single-chain antibody-toxin specific for ErbB-2 and the EGF receptor Int. J. Cancer 65 1996 538
62. B. Steipe Evolutionary approaches to protein engineering Curr. Top. Microbiol. Immunol. 243 1999 55
63. T. Tanaka, and T.H. Rabbitts Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation EMBO J. 22 2003 1025
64. P. Tavladoraki, E. Benvenuto, S. Trinca, D. De Martinis, A. Cattaneo, and P. Galeffi Transgenic plants expressing a functional single-chain Fv antibody are specifically protected from virus attack Nature 366 1993 469
65. E. Tse, M.N. Lobato, A. Forster, T. Tanaka, G.T. Chung, and T.H. Rabbitts Intracellular antibody capture technology: application to selection of intracellular antibodies recognising the BCR-ABL oncogenic protein J. Mol. Biol. 317 2002 85
66. T. Tudyka, and A. Skerra Glutathione S-transferase can be used as a C-terminal, enzymatically active dimerization module for a recombinant protease inhibitor, and functionally secreted into the periplasm of Escherichia coli Protein Sci. 6 1997 2180
67. M. Uhlen, G. Forsberg, T. Moks, M. Hartmanis, and B. Nilsson Fusion proteins in biotechnology Curr. Opin. Biotechnol. 3 1992 363
68. M.A. van Dijk, and J.G. van de Winkel Human antibodies as next generation therapeutics Curr. Opin. Chem. Biol. 5 2001 368
69. M. Visintin, E. Tse, H. Axelson, T.H. Rabbitts, and A. Cattaneo Selection of antibodies for intracellular function using a two-hybrid in vivo system Proc. Natl. Acad. Sci. U. S. A. 96 1999 11723
70. M. Visintin, G. Settanni, A. Maritan, S. Graziosi, J.D. Marks, and A. Cattaneo The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies J. Mol. Biol. 317 2002 73
71. C. Wang, A.F. Castro, D.M. Wilkes, and G.A. Altenberg Expression and purification of the first nucleotide-binding domain and linker region of human multidrug resistance gene product: comparison of fusions to glutathione S-transferase, thioredoxin and maltose-binding protein Biochem. J. 338 1999 77
72. W. Wels, R. Beerli, P. Hellmann, M. Schmidt, B.M. Marte, E.S. Kornilova, A. Hekele, J. Mendelsohn, B. Groner, and N.E. Hynes EGF receptor and p185erbB-2-specific single-chain antibody toxins differ in their cell-killing activity on tumor cells expressing both receptor proteins Int. J. Cancer 60 1995 137
73. P. Wirtz, and B. Steipe Intrabody construction and expression. III: engineering hyperstable V(H) domains Protein Sci. 8 1999 2245
74. A. Wörn, and A. Plückthun Stability engineering of antibody single-chain Fv fragments J. Mol. Biol. 305 2001 989
75. A. Wörn, A. Auf der Maur, D. Escher, A. Honegger, A. Barberis, and A. Plückthun Correlation between in vitro stability and in vivo performance of anti-GCN4 intrabodies as cytoplasmic inhibitors J. Biol. Chem. 275 2000 2795
76. H. Yamazaki, H. Kijima, Y. Ohnishi, Y. Abe, Y. Oshika, T. Tsuchida, T. Tokunaga, A. Tsugu, Y. Ueyama, N. Tamaoki, and M. Nakamura Inhibition of tumor growth by ribozyme-mediated suppression of aberrant epidermal growth factor receptor gene expression J. Natl. Cancer Inst. 90 1998 581
77. Y. Yarden, and A. Ullrich Growth factor receptor tyrosine kinases Annu. Rev. Biochem. 57 1988 443
78. R. Zemel, Y. Berdichevsky, L. Bachmatov, I. Benhar, and R. Tur-Kaspa Inhibition of hepatitis C virus NS3-mediated cell transformation by recombinant intracellular antibodies J. Hepatol. 40 2004 1000
79. L. Zheng, U. Baumann, and J.L. Reymond Production of a functional catalytic antibody ScFv-NusA fusion protein in bacterial cytoplasm J. Biochem. 133 2003 577
80. Q. Zhu, C. Zeng, A. Huhalov, J. Yao, T.G. Turi, D. Danley, T. Hynes, Y. Cong, D. DiMattia, S. Kennedy, G. Daumy, E. Schaeffer, W.A. Marasco, and J.S. Huston Extended half-life and elevated steady-state level of a single-chain Fv intrabody are critical for specific intracellular retargeting of its antigen, caspase-7 J. Immunol. Methods 231 1999 207
81. M.B. Zwick, L.L.C. Bonnycastle, K.A. Noren, S. Venturini, E. Leong, C.F.J. Barbas, C.J. Noren, and J.K. Scott The maltose-binding protein as a scaffold for monovalent display of peptides derived from phage libraries Anal. Biochem. 264 1998 87